ConsInspector 3.0: new library and enhanced functionality
نویسندگان
چکیده
Conslnspector (Freeh et al, 1993) is a program to scan nucleic acid sequences for matches to a pre-compiled library of transcription factor binding sites. The program carries out an extensive examination of binding site candidates; the real sequence is compared with randomly shuffled versions and sequence regions surrounding the conserved binding site are included in the analysis (default 40 bp upstream and 40 bp downstream of the highly conserved core sequence). This feature distinguishes the program from other methods available for the identification of transcription factor binding sites which are restricted to the binding sites: SIGNAL SCAN (Prestridge, 1991, 1996; Prestridge and Stormo, 1993), MATRIX SEARCH (Chen et al, 1995) and Matlnspector (Quandt et al, 1995a). Recently, we showed the quality scores (Q-scores) assigned by Conslnspector to correlate to some extent with biological functionality (Quandt et al, 1995b). Release 3.0 of Conslnspector, with enhanced performance and a considerably extended library of consensus profiles, is available now at ftp://ariane.gsf.de/pub/ or http://www.gsf.de/biodv/. The program Conslnd (Freeh et al, 1993) has been used to compile the library of consensus profiles. The library now encompasses 37 consensus profiles (Release 1.0: 12, Release 2.1: 17 consensus profiles) and is separated into four groups (Table I). The extended weight matrices were deduced from experimentally confirmed binding sequences selected from the TRANSFAC database (Wingender et al, 1996) or directly from the literature. Most consensus profiles of the original library have been improved by the inclusion of additional sequences. Consensus profiles have been compiled from a minimum of nine sequences (Table I). The analysis of DNA sequences for transcription factor binding sites with Conslnspector has improved since Release 1.0:
منابع مشابه
Assessment of "drug-likeness" of a small library of natural products using chemoinformatics
Even though natural products has an excellent record as a source for new drugs, the advent of ultrahigh-throughput screening and large-scale combinatorial synthetic methods, has caused a decline in the use of natural products research in the pharmaceutical industry. This is due to the efficiency in generating and screening a high number of synthetic combinatorial compounds; whereas traditional ...
متن کاملAssessment of "drug-likeness" of a small library of natural products using chemoinformatics
Even though natural products has an excellent record as a source for new drugs, the advent of ultrahigh-throughput screening and large-scale combinatorial synthetic methods, has caused a decline in the use of natural products research in the pharmaceutical industry. This is due to the efficiency in generating and screening a high number of synthetic combinatorial compounds; whereas traditional ...
متن کاملObject-Oriented Interfaces in the Mach 3.0 Multi-Server System
The Mach 3.0 multi-server system decomposes the functionality of the operating system between a micro-kernel, a set of system servers running in user-mode and an emulation library executing in the address space of applications. The interfaces provided by the system servers are objectoriented and both the servers and the emulation library are written in an object-oriented language. In this paper...
متن کاملA New Trust Model for B2C E-Commerce Based on 3D User Interfaces
Lack of trust is one of the key bottle necks in e-commerce development. Nowadays many advanced technologies are trying to address the trust issues in e-commerce. One among them suggests using suitable user interfaces. This paper investigates the functionality and capabilities of 3D graphical user interfaces in regard to trust building in the customers of next generation of B2C e-commerce websit...
متن کاملEvolving Affinity Enhanced Antibodies: High Mutational Rates for Discovery of Coupled Mutations
The expanding market for antibody therapeutics demonstrates the importance of protein engineering. As of 2004, there were 140 protein therapeutics in clinical use within the US and Europe and about 500 more in clinical trials. The success of protein engineering can often be attributed to directed evolutionary approaches resulting in improved or enhanced proteins. However, the primary limitation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Computer applications in the biosciences : CABIOS
دوره 13 1 شماره
صفحات -
تاریخ انتشار 1997